Skip to main content

Site notifications

Samsung Bioepis AU Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

5 result(s) found, displaying 1 to 5
  • Onbevzi (bevacizumab) is a biosimilar of Avastin. Onbevzi has been approved to treat a range of cancers either as a monotherapy or in combination with other anti-cancer medicines
  • Byooviz (ranibizumab) for the treatment of neovascular age-related macular degeneration etc.
  • Australian Public Assessment Report for Adalimumab
  • Australian Public Assessment Report for infliximab

Help us improve this page